121 related articles for article (PubMed ID: 15959455)
1. Differential effect of PARP-2 deletion on brain injury after focal and global cerebral ischemia.
Kofler J; Otsuka T; Zhang Z; Noppens R; Grafe MR; Koh DW; Dawson VL; de Murcia JM; Hurn PD; Traystman RJ
J Cereb Blood Flow Metab; 2006 Jan; 26(1):135-41. PubMed ID: 15959455
[TBL] [Abstract][Full Text] [Related]
2. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA
J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
[TBL] [Abstract][Full Text] [Related]
4. Neuropilin-1 modulates vascular endothelial growth factor-induced poly(ADP-ribose)-polymerase leading to reduced cerebrovascular apoptosis.
Mey L; Hörmann M; Schleicher N; Reuter P; Dönges S; Kinscherf R; Gassmann M; Gerriets T; Al-Fakhri N
Neurobiol Dis; 2013 Nov; 59():111-25. PubMed ID: 23816753
[TBL] [Abstract][Full Text] [Related]
5. Contributions of poly(ADP-ribose) polymerase-1 and -2 to nuclear translocation of apoptosis-inducing factor and injury from focal cerebral ischemia.
Li X; Klaus JA; Zhang J; Xu Z; Kibler KK; Andrabi SA; Rao K; Yang ZJ; Dawson TM; Dawson VL; Koehler RC
J Neurochem; 2010 May; 113(4):1012-22. PubMed ID: 20236222
[TBL] [Abstract][Full Text] [Related]
6. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
[TBL] [Abstract][Full Text] [Related]
7. Distribution of Poly(ADP-ribosyl)ation and cell death after cerebral ischemia in the neonatal rat.
Joly LM; Benjelloun N; Plotkine M; Charriaut-Marlangue C
Pediatr Res; 2003 May; 53(5):776-82. PubMed ID: 12621128
[TBL] [Abstract][Full Text] [Related]
8. Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection.
McCullough LD; Zeng Z; Blizzard KK; Debchoudhury I; Hurn PD
J Cereb Blood Flow Metab; 2005 Apr; 25(4):502-12. PubMed ID: 15689952
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of NU1025, a PARP inhibitor in cerebral ischemia are mediated through reduction in NAD depletion and DNA fragmentation.
Kaundal RK; Shah KK; Sharma SS
Life Sci; 2006 Nov; 79(24):2293-302. PubMed ID: 16935310
[TBL] [Abstract][Full Text] [Related]
10. Endonuclease G does not play an obligatory role in poly(ADP-ribose) polymerase-dependent cell death after transient focal cerebral ischemia.
Xu Z; Zhang J; David KK; Yang ZJ; Li X; Dawson TM; Dawson VL; Koehler RC
Am J Physiol Regul Integr Comp Physiol; 2010 Jul; 299(1):R215-21. PubMed ID: 20427721
[TBL] [Abstract][Full Text] [Related]
11. Poly(ADP-ribose) polymerase impairs early and long-term experimental stroke recovery.
Goto S; Xue R; Sugo N; Sawada M; Blizzard KK; Poitras MF; Johns DC; Dawson TM; Dawson VL; Crain BJ; Traystman RJ; Mori S; Hurn PD
Stroke; 2002 Apr; 33(4):1101-6. PubMed ID: 11935067
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effect of 4-amino-1,8-napthalimide, a poly(ADP ribose) polymerase inhibitor in middle cerebral artery occlusion-induced focal cerebral ischemia in rat.
Kabra DG; Thiyagarajan M; Kaul CL; Sharma SS
Brain Res Bull; 2004 Feb; 62(5):425-33. PubMed ID: 15168908
[TBL] [Abstract][Full Text] [Related]
13. PARP-1 gene disruption in mice preferentially protects males from perinatal brain injury.
Hagberg H; Wilson MA; Matsushita H; Zhu C; Lange M; Gustavsson M; Poitras MF; Dawson TM; Dawson VL; Northington F; Johnston MV
J Neurochem; 2004 Sep; 90(5):1068-75. PubMed ID: 15312162
[TBL] [Abstract][Full Text] [Related]
14. Combined therapy with PJ34, a poly(ADP-ribose)polymerase inhibitor, reduces tissue plasminogen activator-induced hemorrhagic transformations in cerebral ischemia in mice.
Haddad M; Beray-Berthat V; Coqueran B; Plotkine M; Marchand-Leroux C; Margaill I
Fundam Clin Pharmacol; 2013 Aug; 27(4):393-401. PubMed ID: 22436003
[TBL] [Abstract][Full Text] [Related]
15. Sex differences in the response to poly(ADP-ribose) polymerase-1 deletion and caspase inhibition after stroke.
Liu F; Lang J; Li J; Benashski SE; Siegel M; Xu Y; McCullough LD
Stroke; 2011 Apr; 42(4):1090-6. PubMed ID: 21311064
[TBL] [Abstract][Full Text] [Related]
16. Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia.
Moroni F; Meli E; Peruginelli F; Chiarugi A; Cozzi A; Picca R; Romagnoli P; Pellicciari R; Pellegrini-Giampietro DE
Cell Death Differ; 2001 Sep; 8(9):921-32. PubMed ID: 11526447
[TBL] [Abstract][Full Text] [Related]
17. MP-124, a novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitor, ameliorates ischemic brain damage in a non-human primate model.
Matsuura S; Egi Y; Yuki S; Horikawa T; Satoh H; Akira T
Brain Res; 2011 Sep; 1410():122-31. PubMed ID: 21741620
[TBL] [Abstract][Full Text] [Related]
18. Comet assay as a novel approach for studying DNA damage in focal cerebral ischemia: differential effects of NMDA receptor antagonists and poly(ADP-ribose) polymerase inhibitors.
Giovannelli L; Cozzi A; Guarnieri I; Dolara P; Moroni F
J Cereb Blood Flow Metab; 2002 Jun; 22(6):697-704. PubMed ID: 12045668
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of a novel water-soluble poly(ADP-ribose) polymerase-1 inhibitor, MP-124, in in vitro and in vivo models of cerebral ischemia.
Egi Y; Matsuura S; Maruyama T; Fujio M; Yuki S; Akira T
Brain Res; 2011 May; 1389():169-76. PubMed ID: 21420942
[TBL] [Abstract][Full Text] [Related]
20. Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial.
Culman J; Nguyen-Ngoc M; Glatz T; Gohlke P; Herdegen T; Zhao Y
Exp Neurol; 2012 Dec; 238(2):243-53. PubMed ID: 22995601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
